HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$21.09
-0.01 (-0.05%)
▼
5d:
-0.19%
30d:
-0.66%
90d:
-10.67%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 04, 2026
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HSTM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HSTM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.83
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$19.14
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $21.09, which is considered fair relative to its 30-day fair value range of $20.60 to $21.80. The stock's valuation (Forward PE: 24.5) is in line with its historical norms (26.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HSTM is in a strong downtrend. The price is approaching resistance at $21.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSTM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.50 (+44.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a strong downtrend. The price is approaching resistance at $21.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSTM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.50 (+44.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$20.60 -
$21.80
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.6% below Wall St target ($30.50)
Fair Price Analysis
30-Day Fair Range
$20.60 -
$21.80
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$20.20
Resistance Level
$21.53
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.52
Wall Street Target
$30.50
(+44.6%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
-46.5%
Profit Margin
6.0%
Valuation Discount vs History
-2.4% cheaper
PE vs Historical
24.5 vs 26.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.4%
(market-implied from PE analysis)
1-Year Target
$20.58
(-2%)
2-Year Target
$20.09
(-5%)
3-Year Target
$19.61
(-7%)
3-Yr Target (if PE normalizes)
(PE: 25→26)
$21.03
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.5, Growth: 11.0%)
$28.82
(+37%)
Base:
(SPY PE: 22.4, Growth: 11.0%)
$26.26
(+25%)
Bear:
(PE: 19.0, Growth: 11.0%)
$22.32
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 33.34 | Current EPS (TTM): $0.61
Bull Case
$31.54
(+49%)
Analyst growth 41.0%, PE expands to 36.7
Base Case
$28.68
(+36%)
Market implied 41.0%, PE stable at 33.3
Bear Case
$13.83
(-35%)
Severe decline -20.0%, PE contracts to 28.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.5 to 26.3
Stabilization Target:
$22.62
(+7.2%)
PE Expansion Potential:
+7.2%
Share & Embed Analysis
Last updated: March 31, 2026 1:28 AM ET
Data refreshes hourly during market hours. Next update: 2:28 AM
Data refreshes hourly during market hours. Next update: 2:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeff Cunningham
SELL
2100 shares
2025-12-10
Kevin P O'hara
SELL
2000 shares
2025-12-08
Tate Deborah Taylor
SELL
1580 shares
2025-11-26
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 50 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 59 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 61 BUY |
